0001209191-21-006601.txt : 20210201
0001209191-21-006601.hdr.sgml : 20210201
20210201213936
ACCESSION NUMBER: 0001209191-21-006601
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210201
DATE AS OF CHANGE: 20210201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prentiss Christopher B
CENTRAL INDEX KEY: 0001717583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 21578737
MAIL ADDRESS:
STREET 1: 1900 POWELL STREET
STREET 2: SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER NAME:
FORMER CONFORMED NAME: Prentiss Chris
DATE OF NAME CHANGE: 20170921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 1000
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 1000
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-01
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001717583
Prentiss Christopher B
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 1000
EMERYVILLE
CA
94608
0
1
0
0
Chief Financial Officer
Common Stock
2021-02-01
4
S
0
3821
6.36
D
72439
D
Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
The shares were sold at prices ranging from $6.33 to $6.49. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/Christopher Prentiss
2021-02-01